☰

Benjamin J. Frisch, Ph.D. - Publications

Affiliations: 
2012 School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
Pathology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kawano Y, Kawano H, Ghoneim D, Fountaine TJ, Byun DK, LaMere MW, Mendler JH, Ho T, Salama NA, Myers JR, Hussein SE, Frisch BJ, Ashton JM, Azadniv M, Liesveld JL, et al. Myelodysplastic syndromes disable human CD271 VCAM1 CD146 niches supporting normal hematopoietic stem/progenitor cells. Biorxiv : the Preprint Server For Biology. PMID 37066307 DOI: 10.1101/2023.04.09.536176  0.68
2022 Al-Kaabneh B, Frisch B, Aljitawi OS. The Potential Role of 3D In Vitro Acute Myeloid Leukemia Culture Models in Understanding Drug Resistance in Leukemia Stem Cells. Cancers. 14. PMID 36358676 DOI: 10.3390/cancers14215252  0.323
2022 Sharipol A, Lesch ML, Soto CA, Frisch BJ. Bone Marrow Microenvironment-On-Chip for Culture of Functional Hematopoietic Stem Cells. Frontiers in Bioengineering and Biotechnology. 10: 855777. PMID 35795163 DOI: 10.3389/fbioe.2022.855777  0.527
2021 Ackun-Farmmer MA, Alwaseem H, Counts M, Bortz A, Giovani S, Frisch BJ, Fasan R, Benoit DSW. Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone Marrow. Advanced Therapeutics. 5. PMID 35097186 DOI: 10.1002/adtp.202100100  0.415
2021 Soto CA, Lo Celso C, Purton LE, Frisch BJ. From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment. Jbmr Plus. 5: e10516. PMID 34693187 DOI: 10.1002/jbm4.10516  0.369
2021 Ackun-Farmmer MA, Soto CA, Lesch ML, Byun D, Yang L, Calvi LM, Benoit DSW, Frisch BJ. Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21402. PMID 33724567 DOI: 10.1096/fj.202000938RR  0.663
2021 Frisch BJ. Hematopoietic Stem Cell Cultures and Assays. Methods in Molecular Biology (Clifton, N.J.). 2230: 467-477. PMID 33197034 DOI: 10.1007/978-1-0716-1028-2_30  0.396
2019 Calvi LM, Frisch BJ, Kingsley PD, Koniski A, Love TM, Williams JP, Palis J. Acute and late effects of combined internal and external radiation exposures on the hematopoietic system. International Journal of Radiation Biology. 1-49. PMID 31329495 DOI: 10.1080/09553002.2019.1644932  0.605
2019 Frisch BJ, Hoffman CM, Latchney SE, LaMere MW, Myers J, Ashton J, Li AJ, Saunders J, Palis J, Perkins AS, McCabe A, Smith JN, McGrath KE, Rivera-Escalera F, McDavid A, et al. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. Jci Insight. 5. PMID 30998506 DOI: 10.1172/Jci.Insight.124213  0.728
2019 Kawano Y, Byun DK, Frisch BJ, Kawano H, LaMere MW, Johnston CJ, Williams JP, Calvi LM. Local Irradiation Induces Systemic Inflammatory Response and Alteration of the Hematopoietic Stem Cell Niche Blood. 134: 1213-1213. DOI: 10.1182/Blood-2019-131809  0.736
2018 Ayoub E, Wilson MP, McGrath KE, Li AJ, Frisch BJ, Palis J, Calvi LM, Zhang Y, Perkins AS. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nature Communications. 9: 4239. PMID 30315161 DOI: 10.1038/S41467-018-06208-Y  0.616
2018 Staversky RJ, Byun DK, Georger MA, Zaffuto BJ, Goodman A, Becker MW, Calvi LM, Frisch BJ. The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers. Scientific Reports. 8: 14691. PMID 30279500 DOI: 10.1038/S41598-018-32978-Y  0.738
2018 Frisch BJ. The hematopoietic stem cell niche: What's so special about bone? Bone. PMID 29778716 DOI: 10.1016/J.Bone.2018.05.017  0.61
2018 Palis J, McGrath K, Frisch B, Li A, Ayoub E, Zhang YS, Becker M, Perkins A, Calvi L, Steiner L. Modeling Defective Erythropoiesis in Myelodysplastic Syndrome (MDS) Experimental Hematology. 64: S91-S92. DOI: 10.1016/J.Exphem.2018.06.114  0.548
2018 Kousteni S, Frisch BJ, Galan‐Diez M, Calvi LM. The Hematopoietic Niche and Bone Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 966-973. DOI: 10.1002/9781119266594.Ch125  0.734
2017 Alwaseem H, Frisch BJ, Fasan R. Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis. Bioorganic & Medicinal Chemistry. PMID 28826596 DOI: 10.1016/J.Bmc.2017.08.009  0.343
2017 Lawal RA, Zhou X, Batey K, Hoffman CM, Georger MA, Radtke F, Hilton MJ, Xing L, Frisch BJ, Calvi LM. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28277610 DOI: 10.1002/Jbmr.3106  0.773
2016 Staversky RJ, Yang L, Goodman AN, Georger MA, Becker MW, Calvi LM, Frisch BJ. CCL3 Regulates Normal Hematopoiesis but Is Not Essential for the Maintenance of a Long-Term Engrafting Hematopoietic Stem Cell Blood. 128: 1482-1482. DOI: 10.1182/Blood.V128.22.1482.1482  0.787
2015 Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, Georger MA, Evans AG, Liesveld JL, Becker MW, Calvi LM. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood. PMID 26637787 DOI: 10.1182/Blood-2015-06-653113  0.763
2015 Li AJ, Balderman SR, Frisch BJ, LaMere MW, Becker MW, Calvi LM. Restoration of the Bone Marrow Microenvironment Improves Hematopoietic Function in a Murine Model of Myelodysplastic Syndrome Blood. 126: 358-358. DOI: 10.1182/Blood.V126.23.358.358  0.77
2015 Frisch BJ, Goodman AN, Staversky RJ, Bromberg O, Tu X, Bellido TM, Calvi LM. Osteocyte-Mediated Parathyroid Hormone (PTH) Signaling Regulates Hematopoietic Stem Cells Under Physiologic and Continuous PTH Exposure Blood. 126: 1199-1199. DOI: 10.1182/Blood.V126.23.1199.1199  0.739
2014 Frisch BJ, Calvi LM. Osteoblasts as leukemia-initiating cells. Bonekey Reports. 3: 572. PMID 25228985 DOI: 10.1038/Bonekey.2014.67  0.781
2014 Frisch BJ, Calvi LM. Hematopoietic stem cell cultures and assays. Methods in Molecular Biology (Clifton, N.J.). 1130: 315-24. PMID 24482184 DOI: 10.1007/978-1-62703-989-5_24  0.696
2014 Balderman SR, Frisch BJ, LaMere MW, Goodman AN, Becker MW, Calvi LM. Microenvironmental Contribution to Dysfunctional Hematopoiesis in a Murine Model of Myelodysplastic Syndrome Blood. 124: 4359-4359. DOI: 10.1182/Blood.V124.21.4359.4359  0.739
2014 Akwaa F, Rubinova R, Frisch BJ, LaMere MW, O'Dwyer KM, Liesveld JL, Becker MW, Calvi LM. Modulation of Interaction of Human Osteoprogenitor Cells with Hematopoietic Stem and Progenitor Cells Blood. 124: 2933-2933. DOI: 10.1182/Blood.V124.21.2933.2933  0.78
2013 Porter RL, Georger MA, Bromberg O, McGrath KE, Frisch BJ, Becker MW, Calvi LM. Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells (Dayton, Ohio). 31: 372-83. PMID 23169593 DOI: 10.1002/Stem.1286  0.821
2013 Balderman SR, Frisch BJ, LaMere MW, Goodman AN, Becker MW, Calvi LM. Disruption Of The Hematopoietic Stem and Progenitor Cell Pool and Bone Marrow Microenvironment In a Murine Model Of Myelodysplastic Syndrome Blood. 122: 2756-2756. DOI: 10.1182/Blood.V122.21.2756.2756  0.728
2012 Loiselle AE, Frisch BJ, Wolenski M, Jacobson JA, Calvi LM, Schwarz EM, Awad HA, O'Keefe RJ. Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury. Plos One. 7: e40602. PMID 22792383 DOI: 10.1371/Journal.Pone.0040602  0.665
2012 Bromberg O, Frisch BJ, Weber JM, Porter RL, Civitelli R, Calvi LM. Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood. 120: 303-13. PMID 22596259 DOI: 10.1182/Blood-2011-09-377853  0.824
2012 Calvi LM, Bromberg O, Rhee Y, Weber JM, Smith JN, Basil MJ, Frisch BJ, Bellido T. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood. 119: 2489-99. PMID 22262765 DOI: 10.1182/Blood-2011-06-360933  0.828
2012 Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 119: 540-50. PMID 21957195 DOI: 10.1182/Blood-2011-04-348151  0.778
2012 Frisch BJ, Shafiq I, Porter RL, Weber JM, Smith JN, Bromberg O, Basil M, Dhillon RS, Schwarz EM, Calvi LM. Intermittent in Vivo Parathyroid Hormone (PTH) Treatment Results in Jagged 1 (Jag 1) Dependent and Independent Effects On Hematopoietic Stem Cells (HSCs) Blood. 120: 642-642. DOI: 10.1182/Blood.V120.21.642.642  0.828
2010 Frisch BJ, Ashton JM, Jordan CT, Calvi LM. Microenvironmental Changes In An In Vivo Model of Myeloid Leukemia Negatively Regulate Osteoblastic Cells. Blood. 116: 1219-1219. DOI: 10.1182/Blood.V116.21.1219.1219  0.788
2009 Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood. 114: 4054-63. PMID 19726721 DOI: 10.1182/Blood-2009-03-205823  0.847
2009 Weber JM, Frisch BJ, Porter RL, Bromberg O, Olm-shipman AJ, Awad H, Calvi LM. In Vivo Parathyroid Hormone Treatment Expands All Multipotent Primitive Hematopoietic Cell Subsets. Blood. 114: 1449-1449. DOI: 10.1182/Blood.V114.22.1449.1449  0.841
2008 Frisch BJ, Porter RL, Calvi LM. Hematopoietic niche and bone meet. Current Opinion in Supportive and Palliative Care. 2: 211-7. PMID 18685423 DOI: 10.1097/Spc.0B013E32830D5C12  0.817
2008 Porter RL, Frisch BJ, O’Keefe RJ, Calvi LM. Prostaglandin E2 (PGE2) Treatment Rapidly Increases the Fraction of Non-Dividing Hematopoietic Stem Cells (HSCs) Blood. 112: 73-73. DOI: 10.1182/Blood.V112.11.73.73  0.843
2008 Frisch B, Ashton JM, Olm-shipman A, Xing L, Jordan CT, Calvi L. Reciprocal Synergistic Interactions of Leukemic Cells with Osteoclast Progenitors in the Bone Microenvironment Blood. 112: 322-322. DOI: 10.1182/Blood.V112.11.322.322  0.787
2007 Frisch BJ, Weber JM, Porter RL, Gigliotti BJ, Smith JN, Olm-Shipman AJ, O’Keefe RJ, Jordan CT, Calvi LM. In Vivo Treatment with Prostaglandin E2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells. Blood. 110: 1254-1254. DOI: 10.1182/Blood.V110.11.1254.1254  0.83
2006 Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner LA, Guzman ML, Calvi LM. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone. 39: 485-93. PMID 16647886 DOI: 10.1016/J.Bone.2006.03.002  0.771
2006 Calvi LM, Frisch BJ, Gigliotti BJ, Christianson CA, Weber JM, Jordan CT, O’Keefe RJ. Prostaglandin E2 (PGE2) Regulates Osteoblastic Jagged1 and Expands Primitive Hematopoietic Cells In Vivo. Blood. 108: 89-89. DOI: 10.1182/Blood.V108.11.89.89  0.826
2005 Forsythe SR, Weber JM, Christianson CA, Gigliotti BJ, Frisch BJ, Calvi LM. Osteoblastic Cells (OBs) and the Hematopoietic Microenvironment: Parathyroid Hormone (PTH) Increases the Notch Ligand Jagged1 (J1) in a Specific Subpopulation of OBs. Blood. 106: 1396-1396. DOI: 10.1182/Blood.V106.11.1396.1396  0.809
Show low-probability matches.